Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Front Genet ; 10: 1226, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31850074

RESUMEN

Piglet mortality is a complex phenotype that depends on the environment, selection on piglet health, but also on the interaction between the piglet and sow. However, also monogenic recessive defects contribute to piglet mortality. Selective breeding has decreased overall piglet mortality by improving both mothering abilities and piglet viability. However, variants underlying recessive monogenic defects are usually not well captured within the breeding values, potentially drifting to higher frequency as a result of intense selection or genetic drift. This study describes the identification by whole-genome sequencing of a recessive 16-bp deletion in the SPTBN4 gene causing postnatal mortality in a pig breeding line. The deletion induces a frameshift and a premature stop codon, producing an impaired and truncated spectrin beta non-erythrocytic 4 protein (SPTBN4). Applying medium density single nucleotide polymorphism (SNP) data available for all breeding animals, a pregnant carrier sow sired by a carrier boar was identified. Of the resulting piglets, two confirmed homozygous piglets suffered from severe myopathy, hind-limb paralysis, and tremors. Histopathological examination showed dispersed degeneration and decrease of cross-striations in the dorsal and hind-limb muscle fibers of the affected piglets. Hence, the affected piglets are unable to walk or drink, usually resulting in death within a few hours after birth. This study demonstrates how growing genomic resources in pig breeding can be applied to identify rare syndromes in breeding populations, that are usually poorly documented and often are not even known to have a genetic basis. The study allows to prevent carrier-by-carrier matings, thereby gradually decreasing the frequency of the detrimental allele and avoiding the birth of affected piglets, improving animal welfare. Finally, these "natural knockouts" increase our understanding of gene function within the mammalian clade, and provide a potential model for human disease.

2.
Toxicol Pathol ; 33(6): 720-5, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16263697

RESUMEN

As part of regulatory safety testing program, a 13-week oral toxicity study with a new antipsychotic drug candidate was performed in beagle dogs. During this study, dark red/brown feces were recorded in treated dogs and increases in liver parameters (alanine aminotransferase, alkaline phosphatase, bilirubin) were measured biochemically. At the end of the study, livers of high-dose (50 mg/kg) animals were (mottled) dark brown, sometimes with pale foci. Histopathological examination of these livers showed dark globular pigment deposits in the hepatocellular cytoplasm and within the bile canaliculi. Varying numbers of inflammatory cell infiltrates were additionally present in association with the deposits. These pigment deposits showed birefringency with characteristic "Maltese Cross"-like structures under polarized light. Electronmicroscopy revealed the typical, so-called "sunburst" pattern with radiating double-lined crystalline structures. These morphologic characteristics strongly indicated at the presence of porphyrins, which was definitely confirmed biochemically. Published reports of drug-induced hepatic porphyria in dogs are rare. The possible underlying mechanism in the dog and man is discussed.


Asunto(s)
Antipsicóticos/toxicidad , Hígado/efectos de los fármacos , Porfirias Hepáticas/inducido químicamente , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Animales , Antipsicóticos/administración & dosificación , Bilirrubina/sangre , Coagulación Sanguínea/efectos de los fármacos , Perros , Relación Dosis-Respuesta a Droga , Heces/química , Femenino , Hiperplasia , Hígado/enzimología , Hígado/patología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Tiempo de Tromboplastina Parcial , Porfirias Hepáticas/metabolismo , Porfirias Hepáticas/patología , Protoporfirinas/análisis , Protoporfirinas/metabolismo , Timo/efectos de los fármacos , Timo/patología , Pruebas de Toxicidad
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda